Laboratorios Farmaceuticos Rovi, S.A. manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company offers prescription products, including Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor,…
| Métrica | ROVI.MC | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.4% | — |
| Operating Margin | 23.5% | -34.4% | +57.9% |
| Net Margin | 17.9% | -32.5% | +50.4% |
| FCF Margin | 10.4% | -12.6% | +22.9% |
| ROE | 23.9% | -39.2% | +63.1% |
| ROA | 16.4% | -30.9% | +47.4% |
| Current Ratio | 3.13 | 2.73 | +0.40 |
| Debt / Equity | 0.16 | 0.28 | -0.12 |
| Calidad del negocio | FY24 |
|---|---|
| ✓Margen FCF > 10 % | 10.4% |
| ✓ROCE > 10 % | 26.6% |
| ✓Ventas > 5 %/año (3 años) | 5.6% |
| ✓Deuda neta/EBITDA < 3x | 0.4x |
| ✓Reinversión (I+D + capex) > 3 % de ventas | 7.7% |
LABORATORIOS FARMACEUTICOS ROVI S.A cotiza a 58.30 EUR y tiene una capitalización bursátil de €3.0B. Datos fundamentales de los informes financieros anuales oficiales (ESEF) vía filings.xbrl.org; cuentas anuales, sin trimestrales.Más empresas del sector Salud